But as generic drugs continue to play an increasingly prominent role in the health of Americans, we need to also continue to make sure that the generic drug program remains on stable financial footing.
We are going to initiate a public process for trying to gather information for what additional guidelines we could issue to make sure that these ads are providing truthful and non-misleading information.
We must do more than ever to monitor the performance of (device) products after they are approved, and make sure that we are quickly discovering and sharing information about problems that do arise.